G6PD Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)
Condition:   MalariaInterventions:   Drug: Artemether-Lumefantrine (AL) + 0.25 mg/kg primaquine;   Drug: Artemether-Lumefantrine (AL) combination;   Drug: Artemether-Lumefantrine (AL) + 0.4 mg/kg primaquineSponsors:   London School of Hygiene and Tropical Medicine;   Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso;   University Medical Center NijmegenNot yet recruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2014 Category: Research Source Type: clinical trials